Ranibizumab and Risk of Hospitalisation for Ischaemic Stroke and Myocardial Infarction in Patients with Age-Related Macular Degeneration: A Self-Controlled Case-Series Analysis

Overview of attention for article published in Drug Safety, September 2014

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 6,396 followers.

【加齢性黄斑変性症延治療薬ラニビズマブで，脳梗塞リスクが増加するとすれば投与後31 - 60日間。発生率比　1.91 [95%CI 1.13 - 3.24]：自己対照ケースシリーズ323例解析】 Drug Safety http://t.co/8Nv2CDI1Ad

【黄斑変性症治療薬ラニビズマブによる脳梗塞リスク増加は投与後31 - 60日で有意に。発生率比 1.91 [95%CI 1.13 - 3.24]。心筋梗塞リスクの増加は認めず：1204例自己対照ケースシリーズ】 Drug Safety http://t.co/YzoIFufrre

Ranibizumab and Risk of Hospitalisation for Ischaemic Stroke and Myocardial Infarction http://t.co/kJXNpa7uz0